New Delhi, March 25 -- The Indian Medical Association (IMA) has shown concern over the use of the recently introduced GLP-1 drug for the Indian markets, and soon will be giving a memorandum to the Central government regarding its restrictive use to avoid misuse. The GLP-1 has entered the Indian market at a huge discount compared to other drugs that are already available in the country.

Speaking to ANI, the Indian Medical Association President Dr Anil Kumar J. Nayak said, "We will give a memorandum to the govt for restricting prescriptions of GLP-1 drugs to certified endocrinologists/ Diabetologists or MD general medicine to curb misuse."

He further said, "The GLP-1 drug, which was introduced for diabetic patients, is being extensively u...